Search results
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 2 days agoModerna Moderna is one of the captains of a sinking ship. As a leader in the COVID-19 vaccine...
What are the new COVID FLiRT variants, and are they in Wisconsin?
Gannett via AOL· 7 days agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024,...
Q1 2024 Imunon Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 21 hours agoAnd as we reported this morning, enrollment has begun as promised in our Phase 1 vaccine study of immunized 101. A proof-of-concept trial to evaluate the immunization of patients against < ...
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Morningstar· 5 days ago(NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard to treat cancers, today
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 11 hours agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges By Investing.com
Investing.com· 2 days agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19...
Chief medical officer denies straying into political issues during pandemic
Press Association News via AOL· 5 days agoA full transcript of today’s hearing will be available on the website shortly with an accessible...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 7 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days agoBut the science of DNA-based drugs was on the experimental fringe of the biopharma landscape. Not...